Log in to search using one of your social media accounts:

Medicaid restrictions linked to increased late-stage breast cancer diagnoses
(Wiley) Women in Tennessee who were diagnosed with breast cancer were more likely to be diagnosed with late stage disease after a substantial rollback of Medicaid coverage for adults in the state, according to a new analysis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2017 Category: Cancer & Oncology Source Type: news

Study: ACA leads to earlier breast cancer diagnoses
The Affordable Care Act (ACA) is being credited for a shift to earlier breast...Read more on AuntMinnie.comRelated Reading: Study links ACA with earlier cancer diagnosis U.S. House passes bill to repeal and replace ACA How do high-deductible health plans affect radiology? What's next for U.S. healthcare regulation? Mammography use rises with ACA; colonoscopy, not so much (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 23, 2017 Category: Radiology Source Type: news

ACOG Guidance: Individualize Breast Cancer Screening ACOG Guidance: Individualize Breast Cancer Screening
Decisions on when to start and end screening and on screening frequency should be made jointly by patients and providers, given the wide variation in major guidelines, ACOG said.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 23, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

FDA Cancer Drug Approvals in 2017
This slide show highlights some of this year ’s FDA approvals of cancer treatments, including new therapies and indications for breast cancer, lung cancer, and various blood cancers, as well as the first approval based not on disease site but rather by a tumor marker. (Source: CancerNetwork)
Source: CancerNetwork - June 23, 2017 Category: Cancer & Oncology Authors: Cancer Network Editors Source Type: news

ACOG: Shared Decision - Making Key to Breast Cancer Screening
Critically important for patient's value, preferences be factored into process, ACOG leader says (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 23, 2017 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Oncology, Radiology, Surgery, Journal, Source Type: news

Mammogram decision hinges on patient, doctor talk, ob-gyn group says
In updated guidelines on breast cancer screening for average-risk women, a doctor's group emphasized shared decision-making between a woman and her doctor. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 23, 2017 Category: Consumer Health News Source Type: news

Luteolin: How To Reduce Breast Cancer Risk
More than 100 women die of breast cancer in the U.S. every day. It's the second leading cause of cancer deaths in American women. But in my opinion, many of those women really die of a tragic medical error. Let me explain… Millions of women in the U.S. have taken Big Pharma's hormone replacement therapy (HRT). Their doctors prescribe it to try to relieve the symptoms of menopause. Like hot flashes, night sweats, mood swings and weight gain. But what the drug companies try to pass off as hormones are actually synthetic concoctions. They are fake versions of the estrogen and progesterone that your body makes ...
Source: Al Sears, MD Natural Remedies - June 23, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

Women losing out over hormone therapy fears, some experts say
The risk of heart attack, stroke or breast cancer due to hormone replacement therapy has been overstated, and that has scared away some women who could benefit from it, the Society of Obstetricians and Gynaecologists of Canada said at its annual conference in Ottawa this week. (Source: CBC | Health)
Source: CBC | Health - June 23, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

WATCH: What you need to know about the new breast cancer screening rules
Dr. Jennifer Ashton appears live on "GMA" to discuss what women should know about the new breast cancer screening guidelines released by the American College of Obstetricians and Gynecologists. (Source: ABC News: Health)
Source: ABC News: Health - June 23, 2017 Category: Consumer Health News Tags: GMA Source Type: news

Novartis breast cancer drug Kisqali wins European panel backing
ZURICH (Reuters) - A European Medicines Agency (EMA) panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer. (Source: Reuters: Health)
Source: Reuters: Health - June 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

More breast cancers were diagnosed at early stage after Affordable Care Act took effect
(Loyola University Health System) A Loyola University Chicago study published this month has found an increase in the percentage of breast cancer patients who were diagnosed in early Stage 1, after the Affordable Care Act took effect. The increases in Stage 1 diagnoses were higher among African American and Latina breast cancer patients, compared to white patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 23, 2017 Category: Cancer & Oncology Source Type: news

Mammogram Decision Hinges on Patient-Doc Talk, Ob-Gyn Group Says
Updated guidelines say average-risk women can start screening at age 40 (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 23, 2017 Category: Cancer & Oncology Source Type: news

OB/GYN Group Revises Breast Screening Recommendations for Average-Risk Women (FREE)
By Amy Orciari Herman Edited by Andr é Sofair, MD, MPH, and William E. Chavey, MD, MS The American College of Obstetricians and Gynecologists has updated its guidance on breast cancer screening in average-risk women to emphasize shared decision-making between the patient and provider. … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 23, 2017 Category: Primary Care Source Type: news

U.S. physicians move to more flexible mammogram schedule
NEW YORK (Reuters Health) - Women at average risk for breast cancer should be offered screening mammograms every year or two starting at age 40 and they should start regular screening no later than age 50, an influential U.S. group of obstetricians and gynecologists said on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - June 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Mammogram Decision Hinges on Patient-Doc Talk, Ob-Gyn Group Says
THURSDAY, June 22, 2017 -- As the debate continues about the best time for mammograms, the American College of Obstetricians and Gynecologists (ACOG) is asking women to add their voice to the discussion. In updated guidelines on breast cancer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 22, 2017 Category: General Medicine Source Type: news

Post-Breast Cancer Guidelines: Are Providers Listening? Post-Breast Cancer Guidelines: Are Providers Listening?
A recent study found that post-cancer guidelines fall short, but experts argue that those for breast cancer should be clear.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 22, 2017 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news

MRI + mammography detects recurrent breast cancer
Adding MRI to mammography improves the detection of recurrent breast cancer...Read more on AuntMinnie.comRelated Reading: Breast MR hits benchmarks in community practice Short breast MRI protocol works for cancer detection Peers influence use of breast MRI by surgeons Direct invitations boost breast MRI screening rates Does breast MRI hold future for mammography market? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2017 Category: Radiology Source Type: news

Systemic Therapy and Risk of Contralateral Breast Cancer Systemic Therapy and Risk of Contralateral Breast Cancer
After completing tamoxifen or chemotherapy, how long does risk reduction for contralateral breast cancer last?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 22, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
(The JAMA Network Journals) A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2017 Category: Cancer & Oncology Source Type: news

Custom built molecule shows promise as anti-cancer therapy
(University of Bath) Scientists at the University of Bath funded by Cancer Research UK have custom-built a molecule which stops breast cancer cells from multiplying in laboratory trials, and hope it will eventually lead to a treatment for the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2017 Category: Cancer & Oncology Source Type: news

Georgia State hosts first International Triple Negative Breast Cancer Conference
(Georgia State University) Georgia State University will host the First International Triple Negative Breast Cancer Conference from Sept. 18 to 20. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2017 Category: Cancer & Oncology Source Type: news

Dying mother gets her wish to see her daughter graduate  
Patricia Parrotte, a mother dying of breast cancer, got her wish to see her daughter graduate from school when officials worked to bring the ceremony to her hospital room. (Source: the Mail online | Health)
Source: the Mail online | Health - June 21, 2017 Category: Consumer Health News Source Type: news

Komen Arizona to close doors this summer, registration fees for Race for the Cure to be refunded
Susan G. Komen Arizona has begun the processing of closing its doors, with plans to cease operations July 31. Its highly touted Phoenix Race for the Cure event that was scheduled for October is being cancelled. Those who have paid their registration fees for the race will be fully refunded. Local organizations that were selected for Komen grants in March will be funded through March 31, 2018. Komen Ariz ona has contributed more than $26 million for Arizona breast cancer programs and services. In… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 21, 2017 Category: Biotechnology Authors: Angela Gonzales Source Type: news

Komen Arizona to close doors this summer, registration fees for Race for the Cure to be refunded
Susan G. Komen Arizona has begun the processing of closing its doors, with plans to cease operations July 31. Its highly touted Phoenix Race for the Cure event that was scheduled for October is being cancelled. Those who have paid their registration fees for the race will be fully refunded. Local organizations that were selected for Komen grants in March will be funded through March 31, 2018. Komen Ariz ona has contributed more than $26 million for Arizona breast cancer programs and services. In… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 21, 2017 Category: Pharmaceuticals Authors: Angela Gonzales Source Type: news

Real Stories Of Americans Who Will Be Affected By The Proposed Changes To The ACA — And What YOU Can Do To Fight
With the proposed changes to the Affordable Care Act (ACA), 20 million Americans are at risk of losing their health care coverage. A survey, conducted by Brunswick Partners, found that “75 percent of Americans agree that the proposed changes to Medicaid in the AHCA are a bad idea. And that we should not allow 14 million Americans to become uninsured even if there is a potential to reduce Medicaid spending. These results are significant because they find majorities of Americans identifying as conservatives (55 percent), moderates (82 percent) and liberals (90 percent) are opposed to the AHCA’s Medicaid pro...
Source: Healthy Living - The Huffington Post - June 21, 2017 Category: Consumer Health News Source Type: news

Should early-stage breast cancer patients receive CT?
Not performing chest CT on patients with stage I or II breast cancer would...Read more on AuntMinnie.comRelated Reading: NCCN recommends Sirtex's microspheres New NCCN guidelines include breast tomo NCCN guidelines to intermingle with decision support NCCN publishes cancer imaging guidelines NCCN updates non-small cell lung cancer guidelines (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 21, 2017 Category: Radiology Source Type: news

Weight - Loss Program Aids Black Breast Cancer Survivors
Community - based, interventionist - guided weight loss program efficacious for early - stage survivors (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 21, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Journal, Source Type: news

Hair dye and relaxers increase the risk of breast cancer
Rutgers University researchers found that hair dye and chemical relaxers can elevate the chance of developing breast cancer in white and black women. (Source: the Mail online | Health)
Source: the Mail online | Health - June 21, 2017 Category: Consumer Health News Source Type: news

Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President and CEO to Commercialize Proprietary Theralink(R) Tumor Biomarker Platform
Dr. Goix brings 20 years of successful healthcare commercialization experience Two posters were presented at ASCO June 3rd, 2017 for Theralink® Breast Cancer GAITHERSBURG, Maryland, June 21, 2017 -- (Healthcare Sales & Marketing Network) -- Avan... Diagnostics, Oncology, Personnel Avant Diagnostics, Theralink (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2017 Category: Pharmaceuticals Source Type: news

Pharma Leads the Charge on NCDs
A disaster in slow motion; that is how Dr Githinji Gitahi, CEO of African health NGO AMREF, describes the threat of non-communicable diseases (NCDs).Long thought of as diseases of the richer countries, the threat of NCDs – including cancer, diabetes and hypertension – is growing in low-to-middle-income countries, which now account for three-quarters of the annual death toll of more than 40 million.A toxic mix of modernization, urbanization and lifestyle changes has seen this growth in NCDs in developing countries, a scenario that has already played out in developed countries, where smoking, alcohol, processed f...
Source: EyeForPharma - June 21, 2017 Category: Pharmaceuticals Authors: Anonymous Source Type: news

Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?
Title: Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?Category: Health NewsCreated: 6/20/2017 12:00:00 AMLast Editorial Review: 6/21/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 21, 2017 Category: Cancer & Oncology Source Type: news

When Is Risk Highest for Women With Breast Cancer Gene Mutations?
Title: When Is Risk Highest for Women With Breast Cancer Gene Mutations?Category: Health NewsCreated: 6/20/2017 12:00:00 AMLast Editorial Review: 6/21/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 21, 2017 Category: Cancer & Oncology Source Type: news

UC consortium formed to speed up development of new drugs
For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the disease genetically.The journey was long and filled with obstacles, but his persistence paid off.Slamon and colleagues conducted laboratory and clinical research that, in collaboration with biotechnology firm Genentech, helped lead to development of the breast cancer drug Herceptin.UCLA's Dennis Slamon with Harry Connick Jr., who played the professor of medicine in a 2008 television movie.The drug, which targets a specific genetic alteration found in about 25 percent of breast cancer patients, has saved thous...
Source: UCLA Newsroom: Health Sciences - June 21, 2017 Category: Universities & Medical Training Source Type: news

When Is Risk Highest for Women With Breast Cancer Gene Mutations?
Study narrows down peak times, possibly aiding in preventive treatment decisions (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 21, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Research, News, Source Type: news

Women with BRCA gene mutations given clearer picture of breast and ovarian cancer risk
Results of Australian study will provide carriers with greater confidence in decisions they make about prevention strategiesWomen who carry the BRCA1 or BRCA2 gene mutations now have the clearest picture yet of their risk of developing breast and ovarian cancer.An Australian study led by the University of Melbourne, Peter MacCallum Cancer Centre and Cancer Council Victoria tracked almost 10,000 women with these mutations for up to 20 years.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 20, 2017 Category: Science Authors: Australian Associated Press Tags: Breast cancer Genetics Health Cancer research Australia news Ovarian cancer Medical research Source Type: news

Breathing nanoparticles from combustion engines causes Alzheimer's disease... is this why so many city dwellers are losing their minds?
(Natural News) The precise mechanisms of Alzheimer’s disease continue to baffle scientists, but a plethora of recent studies have been shedding some light on this mysterious ailment that kills more people each year than prostate cancer and breast cancer combined. Now, a new study has found that the cause of Alzheimer’s disease is “hiding in... (Source: NaturalNews.com)
Source: NaturalNews.com - June 20, 2017 Category: Consumer Health News Source Type: news

Breast cancer risk higher at certain ages for women with gene mutations: Study
Researchers say they have defined at what age genetic mutations post the greatest risk for women to develop breast and ovarian cancers. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 20, 2017 Category: Consumer Health News Source Type: news

Hair Dyes Tied to Higher Breast Cancer Risk
Study findings differ by race, but one expert says they're inconclusive (Source: WebMD Health)
Source: WebMD Health - June 20, 2017 Category: Consumer Health News Source Type: news

When Is Risk Highest for Women with Breast Cancer Gene Mutations?
Study narrows down peak times, possibly aiding in preventive treatment decisions Source: HealthDay Related MedlinePlus Pages: Breast Cancer, Genes and Gene Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 20, 2017 Category: Consumer Health News Source Type: news

Hair dyes, relaxers may increase breast cancer risk, study says
New research suggests black women who use dark hair dyes face a higher risk of breast cancer, and chemical relaxers and straighteners boost risk in white women. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 20, 2017 Category: Consumer Health News Source Type: news

Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?
Study findings differ by race, but one expert says they're inconclusive (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 20, 2017 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Research, News, Source Type: news

Oh, Lovely: The Tick That Gives People Meat Allergies Is Spreading
By Megan Molteni for WIRED. First comes the unscratchable itching, and the angry blossoming of hives. Then stomach cramping, and — for the unluckiest few — difficulty breathing, passing out, and even death. In the last decade and a half, thousands of previously protein-loving Americans have developed a dangerous allergy to meat. And they all have one thing in common: the lone star tick. Red meat, you might be surprised to know, isn’t totally sugar-free. It contains a few protein-linked saccharides, including one called galactose-alpha-1,3-galactose, or alpha-gal, for short. More and more people are lear...
Source: Healthy Living - The Huffington Post - June 20, 2017 Category: Consumer Health News Source Type: news

Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?
Study findings differ by race, but one expert says they're inconclusive Source: HealthDay Related MedlinePlus Pages: African American Health, Breast Cancer, Cosmetics (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 20, 2017 Category: Consumer Health News Source Type: news

When Is Risk Highest for Women With Breast Cancer Gene Mutations?
TUESDAY, June 20, 2017 -- For women who have genetic mutations that increase their risk of breast and ovarian cancers, researchers have better defined at what age those gene flaws are most likely to cause trouble. Knowing when gene-based cancer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 20, 2017 Category: General Medicine Source Type: news

'Angelina Jolie gene' breast cancer risk determined
The latest Cambridge University-led study of more than 10,000 women gives the most precise estimates to date of breast cancer risk for carriers of a BRCA mutation, researchers claim. (Source: the Mail online | Health)
Source: the Mail online | Health - June 20, 2017 Category: Consumer Health News Source Type: news

NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study Finds
As published in JNCCN, a Siteman Cancer Center study uncovered potential to significantly improve NCCN Guidelines-concordant care in patients with early-stage breast cancer FORT WASHINGTON, Pa., June 20, 2017 -- (Healthcare Sales & Marketing Network) -... Devices, Oncology, Radiology NCCN, NCCN Guidelines, breast MRI, computed tomography (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2017 Category: Pharmaceuticals Source Type: news

Medical News Today: Breast and ovarian cancers: Large study improves estimates of genetic risk
Carriers of faulty BRCA1 and BRCA2 genes have higher risk for breast and ovarian cancer. Now, a large prospective study improves estimates of those risks. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 20, 2017 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?
TUESDAY, June 20, 2017 -- The safety of hair products has been debated for years. Now, new research suggests that black women who use dark hair dyes face a higher risk of breast cancer, while chemical relaxers and straighteners boost the odds in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 20, 2017 Category: General Medicine Source Type: news

When Is Risk Highest for Women With Breast Cancer Gene Mutations?
Study narrows down peak times, possibly aiding in preventive treatment decisions (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 20, 2017 Category: Cancer & Oncology Source Type: news

Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?
Study findings differ by race, but one expert says they're inconclusive (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 20, 2017 Category: Cancer & Oncology Source Type: news